Publications

Full List of Publications in PubMed
Selected Publications
  1. Shi X, Radhakrishnan S, Wen J, Chen JY, Chen J, Lam BA, Mills RE, Stranger BE, Lee C, Setlur SR. Association of CNVs with Methylation Variation.NPJ Genom Med. 2020 Sep 24;5:41.
  2. Dejene S, Du W, Randhawa D, Ohman A, Bradley A, Yadav N, Elias K*, Dinulescu DM*, Setlur SR*. Defining Fallopian Tube-derived miRNA Cancer Signatures. Cancer Med. 2019 Nov;8(15):6709-16.
  3. Yu L, Kim HT, Kasar S, Benien P, Du W, Hoang K, Improgo R, Fernandes S, Radhakrishnan S, Klitgaard J, Lee C, Getz G, Setlur SR*, Brown JR*. Comprehensive Genomic Characterization of 17p Deleted CLL Identifies Novel Driver Mutations and Modulators of Overall Survival. Clin Cancer Res. 2017;23(3):735-45 (*equal contribution).
  4. Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JYH, Ohman A, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM*, Drapkin R*. Transformation of the Fallopian Tube Secretory Epithelium Leads to High-grade Serous Ovarian Cancer in Brca;Tp53;Pten Models. Cancer Cell. 2013;24(6):751-65.
  5. Demichelis F*, Setlur SR*, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C*, Klocker H*, Rubin MA*. Identification of Functionally Active, Low Frequency Copy Number Variants at 15q21.3 and 12q21.31 Associated With Prostate Cancer Risk. Proc Natl Acad Sci U S A. 2012; 109(17):6686-91 (* co-first author).
  6. Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR. Comparison of Familial and Sporadic Chronic Lymphocytic Leukaemia Using High Resolution Array Comparative Genomic Hybridization. Br J Haematol. 2010; 151(4):336-45.
  7. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA,Tang J, Adami H-O, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson S-O, Varenhorst E, Johansson J-E, Brown M, Golub TR, Rubin MA. TMPRSS2-ERG Fusion Prostate Cancer Is a Molecularly Distinct Estrogen-Sensitive Subclass of Aggressive Prostate Cancer. J Natl Cancer Inst 2008; 100:815-25.
  8. Setlur SR, Royce T, Sboner A, Mosquera J-M, Demichelis F, Hofer MD, Mertz KD, Gerstein M, Rubin MA. Integrative Microarray Analysis of Pathways (IMAP) in Metastatic Prostate Cancer. Cancer Res 2007; 67:10296-303.
Back To Top